At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
digitalisdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Digitalis Investigation Group (DIG)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Jul 12, 2016
In Brief
A Phase 3 clinical trial evaluating digitalis for Arrhythmia and 5 related conditions. Completed.
Detailed Summary
To determine if digitalis had a beneficial, harmful, or no effect on total mortality in patients with clinical heart failure and sinus rhythm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Heart Diseases, Heart Failure, Congestive, Sinus Arrhythmia, Heart Failure
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1990
Study CompletionJun 1998
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartJun 1, 1990
Study CompletionJun 1, 1998
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
digitalisdrug